19-1220506-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.597+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000455.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000455.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | MANE Select | c.597+1G>T | splice_donor intron | N/A | NP_000446.1 | |||
| STK11 | NM_001407255.1 | c.597+1G>T | splice_donor intron | N/A | NP_001394184.1 | ||||
| STK11 | NR_176325.1 | n.1864+1G>T | splice_donor intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | TSL:1 MANE Select | c.597+1G>T | splice_donor intron | N/A | ENSP00000324856.6 | |||
| STK11 | ENST00000652231.1 | c.597+1G>T | splice_donor intron | N/A | ENSP00000498804.1 | ||||
| STK11 | ENST00000585748.3 | TSL:3 | c.225+1G>T | splice_donor intron | N/A | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:2
This sequence change affects a donor splice site in intron 4 of the STK11 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Peutz-Jeghers syndrome (PMID: 16407375, 16707622, 21118512, 22775437). This variant is also known as IVS4+1G>T. ClinVar contains an entry for this variant (Variation ID: 265451). Studies have shown that disruption of this splice site results in exon 4 skipping, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 22775437). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
The c.597+1 G>T splice site variant in the STK11 gene has been previously reported in association with Peutz-Jeghers syndrome (Mehenni et al., 2006). This variant destroys the canonical splice donor site in intron 4, and is expected to cause abnormal gene splicing. The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, this variant is pathogenic.
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.597+1G>T intronic pathogenic mutation results from a G to T substitution one nucleotide after coding exon 4 of the STK11 gene. This variant was reported in individual(s) with features consistent with Peutz-Jeghers syndrome (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and may result in the creation or strengthening of a novel splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at